image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 161.07
0.575 %
$ 8.62 B
Market Cap
110.32
P/E
1. INTRINSIC VALUE

Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.[ Read More ]

The intrinsic value of one MASI stock under the base case scenario is HIDDEN Compared to the current market price of 161 USD, Masimo Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart MASI

image
FINANCIALS
2.05 B REVENUE
0.60%
136 M OPERATING INCOME
-35.00%
81.5 M NET INCOME
-43.21%
94.1 M OPERATING CASH FLOW
218.98%
-81.2 M INVESTING CASH FLOW
92.32%
-57.1 M FINANCING CASH FLOW
-10.97%
505 M REVENUE
1.67%
30.1 M OPERATING INCOME
6.36%
9.8 M NET INCOME
-38.75%
25.6 M OPERATING CASH FLOW
-65.64%
-13.5 M INVESTING CASH FLOW
-486.96%
-1.6 M FINANCING CASH FLOW
98.24%
Balance Sheet Decomposition Masimo Corporation
image
Current Assets 1.23 B
Cash & Short-Term Investments 163 M
Receivables 421 M
Other Current Assets 648 M
Non-Current Assets 1.81 B
Long-Term Investments 112 M
PP&E 485 M
Other Non-Current Assets 1.21 B
Current Liabilities 564 M
Accounts Payable 252 M
Short-Term Debt 70.7 M
Other Current Liabilities 242 M
Non-Current Liabilities 1.11 B
Long-Term Debt 918 M
Other Non-Current Liabilities 195 M
EFFICIENCY
Earnings Waterfall Masimo Corporation
image
Revenue 2.05 B
Cost Of Revenue 1.04 B
Gross Profit 1 B
Operating Expenses 867 M
Operating Income 136 M
Other Expenses 55 M
Net Income 81.5 M
RATIOS
49.00% GROSS MARGIN
49.00%
6.66% OPERATING MARGIN
6.66%
3.98% NET MARGIN
3.98%
5.97% ROE
5.97%
2.68% ROA
2.68%
5.52% ROIC
5.52%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Masimo Corporation
image
Net Income 81.5 M
Depreciation & Amortization 98.3 M
Capital Expenditures -44 M
Stock-Based Compensation 7 M
Change in Working Capital -70.9 M
Others -60.2 M
Free Cash Flow 6.4 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Masimo Corporation
image
Wall Street analysts predict an average 1-year price target for MASI of $164 , with forecasts ranging from a low of $148 to a high of $170 .
MASI Lowest Price Target Wall Street Target
148 USD -8.11%
MASI Average Price Target Wall Street Target
164 USD 1.59%
MASI Highest Price Target Wall Street Target
170 USD 5.54%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
1 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Masimo Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
5.45 M USD 1
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
6 months ago
Apr 26, 2024
Sell 5.45 M USD
REYNOLDS CRAIG B
Director
- 40000
136.1654 USD
1 year ago
May 25, 2023
Bought 79.1 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 500
158.188 USD
1 year ago
May 25, 2023
Bought 357 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 2265
157.5337 USD
1 year ago
May 25, 2023
Bought 564 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 3600
156.7874 USD
1 year ago
Dec 15, 2022
Bought 225 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 1541
146.2294 USD
1 year ago
Dec 15, 2022
Bought 296 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 2039
145.217 USD
1 year ago
Dec 15, 2022
Bought 346 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 2397
144.1867 USD
1 year ago
Dec 15, 2022
Bought 152 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 1063
143.2737 USD
2 years ago
Nov 14, 2022
Bought 37.5 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 300
124.99 USD
2 years ago
Nov 14, 2022
Bought 2.06 M USD
KIANI JOE E
CEO and Chairman of the Board
+ 16537
124.4453 USD
2 years ago
Nov 14, 2022
Bought 1.87 M USD
KIANI JOE E
CEO and Chairman of the Board
+ 15157
123.4783 USD
2 years ago
Nov 11, 2022
Bought 144 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 1100
130.5573 USD
2 years ago
Nov 11, 2022
Bought 327 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 2514
129.9012 USD
2 years ago
Nov 11, 2022
Bought 383 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 2969
128.8602 USD
2 years ago
Nov 11, 2022
Bought 153 K USD
KIANI JOE E
CEO and Chairman of the Board
+ 1201
127.7968 USD
2 years ago
Jan 24, 2022
Sell 129 K USD
Mikkelson Adam
Director
- 600
214.8 USD
2 years ago
Jan 18, 2022
Sell 137 K USD
Mikkelson Adam
Director
- 600
228.7 USD
2 years ago
Jan 10, 2022
Sell 150 K USD
Mikkelson Adam
Director
- 600
250.01 USD
2 years ago
Dec 06, 2021
Sell 826 K USD
Levy Tao
EVP, Bus Dev
- 3000
275.47 USD
3 years ago
Nov 17, 2021
Sell 9.8 M USD
KIANI JOE E
CEO and Chairman of the Board
- 32597
300.5373 USD
3 years ago
Nov 18, 2021
Sell 6.12 M USD
KIANI JOE E
CEO and Chairman of the Board
- 20399
300.052 USD
2 years ago
Nov 19, 2021
Sell 2.53 M USD
KIANI JOE E
CEO and Chairman of the Board
- 8416
300.8326 USD
3 years ago
Nov 12, 2021
Sell 1.1 M USD
Young Micah W
EVP & Chief Financial Officer
- 3700
298 USD
3 years ago
Nov 12, 2021
Sell 2.56 M USD
KIANI JOE E
CEO and Chairman of the Board
- 8549
300.0316 USD
3 years ago
Nov 15, 2021
Sell 8.32 M USD
KIANI JOE E
CEO and Chairman of the Board
- 27599
301.3611 USD
3 years ago
Nov 16, 2021
Sell 732 K USD
KIANI JOE E
CEO and Chairman of the Board
- 2440
300.0149 USD
3 years ago
Nov 03, 2021
Sell 58 K USD
KIANI JOE E
CEO and Chairman of the Board
- 200
290.1737 USD
3 years ago
Nov 04, 2021
Sell 1.21 M USD
KIANI JOE E
CEO and Chairman of the Board
- 4173
290.1639 USD
3 years ago
Nov 02, 2021
Sell 4.44 M USD
KIANI JOE E
CEO and Chairman of the Board
- 15223
291.4554 USD
3 years ago
Oct 29, 2021
Sell 5.52 M USD
KIANI JOE E
CEO and Chairman of the Board
- 18967
290.9674 USD
3 years ago
Nov 01, 2021
Sell 995 K USD
KIANI JOE E
CEO and Chairman of the Board
- 3429
290.0774 USD
3 years ago
Nov 02, 2021
Sell 2.4 M USD
KIANI JOE E
CEO and Chairman of the Board
- 8223
291.4554 USD
3 years ago
Oct 26, 2021
Sell 754 K USD
KIANI JOE E
CEO and Chairman of the Board
- 2600
290.1022 USD
3 years ago
Oct 27, 2021
Sell 5.77 M USD
KIANI JOE E
CEO and Chairman of the Board
- 19853
290.5451 USD
3 years ago
Oct 26, 2021
Sell 7.96 M USD
KIANI JOE E
CEO and Chairman of the Board
- 27332
291.2302 USD
3 years ago
May 11, 2021
Bought 107 K USD
McClenahan Thomas Samuel
EVP, GEN COUNSEL & CORP SEC
+ 500
214.4 USD
3 years ago
May 03, 2021
Bought 115 K USD
McClenahan Thomas Samuel
EVP, GEN COUNSEL & CORP SEC
+ 500
230 USD
3 years ago
Apr 30, 2021
Bought 117 K USD
McClenahan Thomas Samuel
EVP, GEN COUNSEL & CORP SEC
+ 500
233.24 USD
3 years ago
Apr 08, 2021
Sell 499 K USD
Young Micah W
EVP & Chief Financial Officer
- 2087
239 USD
3 years ago
Jan 12, 2021
Sell 954 K USD
KIANI JOE E
CEO and Chairman of the Board
- 3403
280.324 USD
3 years ago
Jan 11, 2021
Sell 2.8 M USD
REYNOLDS CRAIG B
Director
- 10000
279.7412 USD
3 years ago
Jan 07, 2021
Sell 432 K USD
KIANI JOE E
CEO and Chairman of the Board
- 1542
280.0476 USD
3 years ago
Jan 08, 2021
Sell 14.9 M USD
KIANI JOE E
CEO and Chairman of the Board
- 52698
281.927 USD
3 years ago
Jan 11, 2021
Sell 2.53 M USD
KIANI JOE E
CEO and Chairman of the Board
- 9034
280.4475 USD
3 years ago
Dec 28, 2020
Sell 2.18 M USD
Coleman Jon
Pres-WW OEM & Global Health
- 8250
264.02 USD
3 years ago
Dec 15, 2020
Sell 3.98 M USD
Sampath Anand
EVP, Ops & Clinical Research
- 15000
265.6103 USD
3 years ago
Dec 15, 2020
Sell 3.98 M USD
Sampath Anand
EVP, Ops & Clinical Research
- 15000
265.5767 USD
3 years ago
Dec 10, 2020
Sell 9.91 M USD
KIANI JOE E
CEO and Chairman of the Board
- 36626
270.5 USD
3 years ago
Dec 11, 2020
Sell 1.64 M USD
KIANI JOE E
CEO and Chairman of the Board
- 6038
271.3073 USD
3 years ago
Dec 09, 2020
Sell 369 K USD
KIANI JOE E
CEO and Chairman of the Board
- 1365
270.3302 USD
3 years ago
Dec 08, 2020
Sell 15.2 M USD
KIANI JOE E
CEO and Chairman of the Board
- 55971
270.6807 USD
3 years ago
Dec 03, 2020
Sell 23.2 M USD
KIANI JOE E
CEO and Chairman of the Board
- 88312
263.1306 USD
3 years ago
Dec 04, 2020
Sell 3.06 M USD
KIANI JOE E
CEO and Chairman of the Board
- 11688
261.5001 USD
4 years ago
Oct 27, 2020
Sell 2.5 M USD
REYNOLDS CRAIG B
Director
- 10000
250 USD
4 years ago
Oct 27, 2020
Sell 11.9 M USD
KIANI JOE E
CEO and Chairman of the Board
- 47508
250.4666 USD
4 years ago
Oct 19, 2020
Sell 2.39 M USD
Young Micah W
EVP & Chief Financial Officer
- 10000
239 USD
4 years ago
Oct 12, 2020
Sell 2.39 M USD
REYNOLDS CRAIG B
Director
- 10000
239.34 USD
4 years ago
Oct 12, 2020
Sell 2.41 M USD
REYNOLDS CRAIG B
Director
- 10000
240.87 USD
4 years ago
Oct 07, 2020
Sell 13.2 M USD
KIANI JOE E
CEO and Chairman of the Board
- 52492
250.867 USD
4 years ago
Oct 07, 2020
Sell 1.27 M USD
McClenahan Thomas Samuel
EVP, GEN COUNSEL & CORP SEC
- 5000
254 USD
4 years ago
Oct 07, 2020
Sell 2.5 M USD
Lee Yongsam
EVP, CIO
- 10000
250 USD
4 years ago
Oct 07, 2020
Sell 6.28 M USD
Muhsin Bilal
Chief Operating Officer
- 25000
251 USD
4 years ago
Jul 06, 2020
Sell 294 K USD
Coleman Jon
Pres-WW Sales,Pro Svc,Med Affs
- 1250
235 USD
4 years ago
Jun 08, 2020
Sell 324 K USD
Mikkelson Adam
Director
- 1498
216.01 USD
4 years ago
Jun 04, 2020
Sell 132 K USD
Cohen H Michael
Director
- 587
225.37 USD
4 years ago
Apr 22, 2020
Sell 2.27 M USD
KIANI JOE E
CEO and Chairman of the Board
- 11336
200.2691 USD
4 years ago
Apr 17, 2020
Sell 22.4 M USD
KIANI JOE E
CEO and Chairman of the Board
- 111468
200.7007 USD
4 years ago
Apr 16, 2020
Sell 21.5 M USD
KIANI JOE E
CEO and Chairman of the Board
- 105318
204.1275 USD
4 years ago
Apr 14, 2020
Sell 21.4 M USD
KIANI JOE E
CEO and Chairman of the Board
- 112578
190.4392 USD
4 years ago
Apr 15, 2020
Sell 2.17 M USD
KIANI JOE E
CEO and Chairman of the Board
- 11208
193.2158 USD
4 years ago
Apr 15, 2020
Sell 14.4 M USD
KIANI JOE E
CEO and Chairman of the Board
- 71878
200.5682 USD
4 years ago
Apr 15, 2020
Sell 289 K USD
Young Micah W
EVP & Chief Financial Officer
- 1447
200.0008 USD
4 years ago
Apr 15, 2020
Sell 417 K USD
Young Micah W
EVP & Chief Financial Officer
- 2087
200.0144 USD
4 years ago
Apr 14, 2020
Sell 380 K USD
Coleman Jon
Pres-WW Sales,Pro Svc,Med Affs
- 2000
190 USD
4 years ago
Apr 15, 2020
Sell 390 K USD
Coleman Jon
Pres-WW Sales,Pro Svc,Med Affs
- 2000
195 USD
4 years ago
Apr 15, 2020
Sell 400 K USD
Coleman Jon
Pres-WW Sales,Pro Svc,Med Affs
- 2000
200 USD
4 years ago
Apr 14, 2020
Sell 1.11 M USD
Lee Yongsam
EVP, CIO
- 6000
185.0192 USD
4 years ago
Apr 13, 2020
Sell 1.8 M USD
Lee Yongsam
EVP, CIO
- 10000
180 USD
4 years ago
Apr 14, 2020
Sell 740 K USD
Lee Yongsam
EVP, CIO
- 4000
185.0024 USD
4 years ago
Apr 14, 2020
Sell 573 K USD
McClenahan Thomas Samuel
EVP, GEN COUNSEL & CORP SEC
- 3000
191 USD
4 years ago
Apr 14, 2020
Sell 1.34 M USD
McClenahan Thomas Samuel
EVP, GEN COUNSEL & CORP SEC
- 7000
191.009 USD
4 years ago
Apr 14, 2020
Sell 478 K USD
Van Ramshorst David J
SVP, Chief Accounting Officer
- 2500
191 USD
4 years ago
Apr 14, 2020
Sell 1.9 M USD
Barker Steven
Director
- 10000
190.0045 USD
4 years ago
Apr 13, 2020
Sell 3.56 M USD
Sampath Anand
EVP, Ops & Clinical Research
- 19796
180 USD
4 years ago
Apr 14, 2020
Sell 1.79 M USD
REYNOLDS CRAIG B
Director
- 9752
184 USD
4 years ago
Apr 08, 2020
Sell 3.34 M USD
KIANI JOE E
CEO and Chairman of the Board
- 18024
185.2731 USD
4 years ago
Apr 09, 2020
Sell 9.64 M USD
KIANI JOE E
CEO and Chairman of the Board
- 51942
185.5894 USD
4 years ago
Apr 06, 2020
Sell 5.19 M USD
KIANI JOE E
CEO and Chairman of the Board
- 28008
185.3071 USD
4 years ago
Apr 03, 2020
Sell 5.33 M USD
KIANI JOE E
CEO and Chairman of the Board
- 28716
185.6456 USD
4 years ago
Apr 03, 2020
Sell 1.38 M USD
KIANI JOE E
CEO and Chairman of the Board
- 7439
185.0719 USD
4 years ago
Apr 06, 2020
Sell 374 K USD
Van Ramshorst David J
SVP, Chief Accounting Officer
- 2000
187 USD
4 years ago
Apr 06, 2020
Sell 920 K USD
Muhsin Bilal
Chief Operating Officer
- 5000
184 USD
4 years ago
Mar 30, 2020
Sell 274 K USD
Van Ramshorst David J
SVP, Chief Accounting Officer
- 1500
183 USD
4 years ago
Mar 27, 2020
Sell 131 K USD
Van Ramshorst David J
SVP, Chief Accounting Officer
- 723
181 USD
4 years ago
Mar 27, 2020
Sell 179 K USD
Van Ramshorst David J
SVP, Chief Accounting Officer
- 1000
179 USD
4 years ago
Mar 13, 2020
Sell 4.45 M USD
KIANI JOE E
CEO and Chairman of the Board
- 23982
185.7603 USD
4 years ago
Mar 12, 2020
Sell 1.84 M USD
KIANI JOE E
CEO and Chairman of the Board
- 9827
187.1607 USD
4 years ago
Mar 10, 2020
Sell 9.16 M USD
KIANI JOE E
CEO and Chairman of the Board
- 50569
181.0903 USD
4 years ago
Mar 11, 2020
Sell 1.53 M USD
KIANI JOE E
CEO and Chairman of the Board
- 8276
185.1019 USD
4 years ago
Mar 11, 2020
Sell 19.8 M USD
KIANI JOE E
CEO and Chairman of the Board
- 109087
181.7779 USD
4 years ago
Feb 04, 2020
Sell 211 K USD
McClenahan Thomas Samuel
EVP & General Counsel
- 1200
176.0104 USD
4 years ago
Feb 05, 2020
Sell 1.32 M USD
McClenahan Thomas Samuel
EVP & General Counsel
- 7477
176.504 USD
4 years ago
Feb 06, 2020
Sell 233 K USD
McClenahan Thomas Samuel
EVP & General Counsel
- 1323
176.0399 USD
4 years ago
Jan 22, 2020
Sell 1.75 M USD
Barker Steven
Director
- 10000
175.0001 USD
4 years ago
Jan 17, 2020
Sell 272 K USD
Young Micah W
EVP & Chief Financial Officer
- 1599
170.0638 USD
4 years ago
Jan 16, 2020
Sell 1.43 M USD
Young Micah W
EVP & Chief Financial Officer
- 8401
170.0075 USD
4 years ago
Dec 20, 2019
Sell 144 K USD
McClenahan Thomas Samuel
EVP & General Counsel
- 907
159.02 USD
4 years ago
Dec 20, 2019
Sell 1.11 M USD
McClenahan Thomas Samuel
EVP & General Counsel
- 7000
159.03 USD
4 years ago
Dec 19, 2019
Sell 79.6 K USD
McClenahan Thomas Samuel
EVP & General Counsel
- 500
159.288 USD
4 years ago
Dec 17, 2019
Sell 96.5 K USD
McClenahan Thomas Samuel
EVP & General Counsel
- 607
159 USD
4 years ago
Dec 18, 2019
Sell 157 K USD
McClenahan Thomas Samuel
EVP & General Counsel
- 986
159.001 USD
4 years ago
Dec 16, 2019
Sell 3.76 M USD
Lee Yongsam
EVP & CIO
- 24000
156.8368 USD
4 years ago
Dec 06, 2019
Sell 1.09 M USD
FITCH SANFORD
Director
- 7000
156.2733 USD
4 years ago
Nov 20, 2019
Sell 2.33 M USD
Sampath Anand
EVP, Ops & Clinical Research
- 15000
155.0001 USD
4 years ago
Nov 20, 2019
Sell 1.65 M USD
Lee Yongsam
EVP & CIO
- 10675
155.0332 USD
5 years ago
Nov 19, 2019
Sell 280 K USD
Lee Yongsam
EVP & CIO
- 1825
153.1603 USD
5 years ago
Nov 18, 2019
Sell 450 K USD
Muhsin Bilal
Chief Operating Officer
- 3000
150 USD
5 years ago
Nov 04, 2019
Sell 956 K USD
FITCH SANFORD
Director
- 6500
147.0804 USD
5 years ago
Oct 01, 2019
Sell 971 K USD
FITCH SANFORD
Director
- 6500
149.4256 USD
5 years ago
Sep 16, 2019
Sell 313 K USD
Young Micah W
EVP & Chief Financial Officer
- 2087
150.0199 USD
5 years ago
Aug 22, 2019
Sell 1.05 M USD
FITCH SANFORD
Director
- 7000
150.39 USD
5 years ago
Aug 19, 2019
Sell 164 K USD
Lee Yongsam
EVP & CIO
- 1078
152.4227 USD
5 years ago
Aug 14, 2019
Sell 19.7 K USD
Lee Yongsam
EVP & CIO
- 130
151.4656 USD
5 years ago
Aug 16, 2019
Sell 372 K USD
Lee Yongsam
EVP & CIO
- 2454
151.4049 USD
5 years ago
Aug 13, 2019
Sell 590 K USD
Lee Yongsam
EVP & CIO
- 3838
153.6216 USD
5 years ago
Aug 12, 2019
Sell 591 K USD
Lee Yongsam
EVP & CIO
- 3857
153.345 USD
5 years ago
Aug 01, 2019
Sell 210 K USD
KIANI JOE E
CEO and Chairman of the Board
- 1310
160 USD
5 years ago
Jul 31, 2019
Sell 3.3 M USD
KIANI JOE E
CEO and Chairman of the Board
- 20597
160.0109 USD
5 years ago
Jul 26, 2019
Sell 2.95 M USD
KIANI JOE E
CEO and Chairman of the Board
- 18437
160.0229 USD
5 years ago
Jul 26, 2019
Sell 1.6 M USD
Barker Steven
Director
- 10000
160 USD
5 years ago
Jul 11, 2019
Sell 808 K USD
Lee Yongsam
EVP & CIO
- 5339
151.3295 USD
5 years ago
Jul 12, 2019
Sell 909 K USD
Lee Yongsam
EVP & CIO
- 5989
151.8345 USD
5 years ago
Jul 15, 2019
Sell 180 K USD
Lee Yongsam
EVP & CIO
- 1172
153.9773 USD
5 years ago
Jul 01, 2019
Sell 15 M USD
KIANI JOE E
CEO and Chairman of the Board
- 100000
150.14 USD
5 years ago
Jul 01, 2019
Sell 1.5 M USD
Barker Steven
Director
- 10000
150 USD
5 years ago
Jun 27, 2019
Sell 37.4 K USD
Lee Yongsam
EVP & CIO
- 258
145 USD
5 years ago
Jun 25, 2019
Sell 107 K USD
Lee Yongsam
EVP & CIO
- 736
145.33 USD
5 years ago
Jun 26, 2019
Sell 14.5 K USD
Lee Yongsam
EVP & CIO
- 100
145.01 USD
5 years ago
Jun 21, 2019
Sell 190 K USD
Lee Yongsam
EVP & CIO
- 1301
146.22 USD
5 years ago
Jun 24, 2019
Sell 156 K USD
Lee Yongsam
EVP & CIO
- 1070
145.51 USD
5 years ago
Jun 18, 2019
Sell 398 K USD
Lee Yongsam
EVP & CIO
- 2728
145.98 USD
5 years ago
Jun 19, 2019
Sell 145 K USD
Lee Yongsam
EVP & CIO
- 1000
145.49 USD
5 years ago
Jun 20, 2019
Sell 447 K USD
Lee Yongsam
EVP & CIO
- 3035
147.13 USD
5 years ago
Jun 14, 2019
Sell 2.14 M USD
Sampath Anand
EVP, Ops & Clinical Research
- 15000
142.39 USD
5 years ago
Jun 14, 2019
Sell 2.14 M USD
Sampath Anand
EVP, Ops & Clinical Research
- 15000
142.38 USD
5 years ago
Jun 10, 2019
Sell 1.4 M USD
Muhsin Bilal
Chief Operating Officer
- 10000
140 USD
5 years ago
Jun 05, 2019
Sell 1.35 M USD
Muhsin Bilal
Chief Operating Officer
- 10000
135 USD
5 years ago
May 16, 2019
Sell 218 K USD
Van Ramshorst David J
Chief Accounting Officer
- 1500
145 USD
5 years ago
May 16, 2019
Sell 1.45 M USD
Barker Steven
Director
- 10000
145 USD
7. News
Masimo to Present in Stifel 2024 Healthcare Conference IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industr. businesswire.com - 3 days ago
Masimo's Q3 Earnings Rise Y/Y, Healthcare Demand Drives Growth MAMO sees a 30.7% increase in non-GAAP operating income in Q3 2024. Healthcare segment revenues increase 11.5%, driving overall growth amid strategic shifts. zacks.com - 1 week ago
MASI Stock Gains Following Q3 Earnings Beat, Gross Margin Expands Masimo's third-quarter 2024 results continue to benefit from the strength in its Healthcare business. zacks.com - 1 week ago
Masimo Corporation (MASI) Q3 2024 Earnings Call Transcript Masimo Corporation (NASDAQ:MASI ) Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ET Company Participants Eli Kammerman - VP of Business Development and IR Michelle Brennan - Interim CEO Micah Young - EVP and CFO Bilal Muhsin - COO Conference Call Participants Jason Bednar - Piper Sandler Marie Thibault - BTIG Michael Polark - Wolfe Research Frederick Wise - Stifel Matt Taylor - Jefferies Vik Chopra - Wells Fargo Michael Matson - Needham Jayson Bedford - Raymond James Operator Ladies and gentlemen, good afternoon, and welcome to Masimo's Third Quarter 2024 Earnings Conference Call. The company's press release is available at www.masimo.com. seekingalpha.com - 1 week ago
Masimo (MASI) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Although the revenue and EPS for Masimo (MASI) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 1 week ago
Masimo (MASI) Q3 Earnings and Revenues Top Estimates Masimo (MASI) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.63 per share a year ago. zacks.com - 1 week ago
Masimo (MASI) Reports Next Week: Wall Street Expects Earnings Growth Masimo (MASI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com - 2 weeks ago
Vanderbilt University Medical Center Integrates Masimo Radius VSM™ in Proactive Care Protocol to Combat Emergency Room Congestion IRVINE, Calif.--(BUSINESS WIRE)--Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring technology in the ED. businesswire.com - 2 weeks ago
Apple wins $250 from Masimo in watch patent trial A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn't getting a big payday. techcrunch.com - 3 weeks ago
Masimo smartwatches infringe Apple design patents, US jury says Apple convinced a federal jury on Friday that health monitoring tech company Masimo's smartwatches infringe two of its design patents. reuters.com - 3 weeks ago
Will Masimo (MASI) Beat Estimates Again in Its Next Earnings Report? Masimo (MASI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. zacks.com - 3 weeks ago
Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company's Board of Directors (the “Board”), effective immediately. Following these appointments, the Board will consist of eight directors. Quentin Koffey, Lead Independent Director of Masimo, stated, “We are pleased to welcome Tim and Wendy as our newest independent directors. Both are high-caliber professionals. businesswire.com - 4 weeks ago
8. Profile Summary

Masimo Corporation MASI

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 8.62 B
Dividend Yield 0.00%
Description Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
Contact 52 Discovery, Irvine, CA, 92618 https://www.masimo.com
IPO Date Aug. 8, 2007
Employees 3800
Officers Tetsuro Maniwa President of Masimo Japan Ms. Michelle M. Brennan Interim Chief Executive Officer & Director Dr. Steven J. Barker Chairman of Scientific Advisory Board & Chief Science Officer Mr. Blair Tripodi Chief Operating Officer of Consumer Division Mr. Tao Leopold Levy Executive Vice President of Business Development Mr. Anand Sampath Executive Vice President of Operations & Clinical Research Mr. Eli Kammerman Vice President of Business Development & Investor Relations Mr. Bilal Muhsin Chief Operating Officer Mr. Paul Hataishi Senior Vice President & Chief Accounting Officer Mr. Yongsam Lee Executive Vice President & Chief Information Officer